VGHAX Holdings — Vanguard Health Care Fund
All 103 reported holdings of Vanguard Health Care Fund (VGHAX) by percentage of net assets, from the fund's latest SEC N-PORT filing.
| Holding | % of net assets | Value (USD) |
|---|---|---|
| Eli Lilly & Co | 9.08% | $3.35B |
| Merck & Co Inc | 5.41% | $2.00B |
| AstraZeneca PLC | 5.09% | $1.88B |
| UnitedHealth Group Inc | 3.92% | $1.44B |
| Johnson & Johnson | 3.45% | $1.27B |
| Edwards Lifesciences Corp | 3.21% | $1.18B |
| Gsk PLC | 3.13% | $1.15B |
| Intuitive Surgical Inc | 2.71% | $1.00B |
| Boston Scientific Corp | 2.36% | $868.21M |
| Danaher Corp | 2.35% | $865.49M |
| CVS Health Corp | 2.20% | $812.63M |
| Argenx SE | 2.20% | $812.57M |
| Abbott Laboratories | 2.18% | $802.77M |
| Vertex Pharmaceuticals Inc | 2.09% | $770.10M |
| Cencora Inc | 2.08% | $765.24M |
| Elevance Health Inc | 1.90% | $699.52M |
| Regeneron Pharmaceuticals Inc | 1.79% | $658.90M |
| Ucb SA | 1.74% | $641.37M |
| Novartis AG | 1.62% | $597.54M |
| HCA Healthcare Inc | 1.42% | $522.82M |
| Alnylam Pharmaceuticals Inc | 1.40% | $517.06M |
| AbbVie Inc | 1.35% | $497.89M |
| Biogen Inc | 1.30% | $478.14M |
| United Therapeutics Corp | 1.28% | $470.16M |
| Galderma Group AG | 1.27% | $467.55M |
| Chugai Pharmaceutical Co Ltd | 1.25% | $458.96M |
| Roche Holding AG | 1.24% | $457.40M |
| Otsuka Holdings Co Ltd | 1.23% | $452.39M |
| Cardinal Health Inc | 1.21% | $446.96M |
| Agilent Technologies Inc | 1.20% | $441.89M |
| Shionogi & Co Ltd | 1.12% | $412.94M |
| Dexcom Inc | 1.03% | $379.05M |
| Daiichi Sankyo Co Ltd | 1.00% | $368.34M |
| Thermo Fisher Scientific Inc | 0.97% | $357.16M |
| Genmab A/S | 0.97% | $356.37M |
| Medtronic PLC | 0.93% | $342.35M |
| Stryker Corp | 0.83% | $305.84M |
| Ionis Pharmaceuticals Inc | 0.77% | $284.33M |
| REVOLUTION Medicines Inc | 0.72% | $264.95M |
| Ascendis Pharma A/S | 0.65% | $240.84M |
| Steris PLC | 0.64% | $237.01M |
| Incyte Corp | 0.61% | $225.37M |
| Qiagen NV | 0.61% | $225.27M |
| Cytokinetics Inc | 0.60% | $222.78M |
| Bristol-Myers Squibb Co | 0.60% | $221.86M |
| Eisai Co Ltd | 0.60% | $219.69M |
| Madrigal Pharmaceuticals Inc | 0.57% | $211.57M |
| Icon PLC | 0.49% | $182.00M |
| Novo Nordisk A/S | 0.48% | $175.73M |
| CG oncology Inc | 0.47% | $172.81M |
| HeartFlow Inc | 0.46% | $168.54M |
| Avantor Inc | 0.45% | $165.89M |
| Scholar Rock Holding Corp | 0.44% | $161.58M |
| Encompass Health Corp | 0.43% | $160.00M |
| Vaxcyte Inc | 0.41% | $152.68M |
| Xenon Pharmaceuticals Inc | 0.41% | $149.97M |
| Kymera Therapeutics Inc | 0.40% | $145.64M |
| Alignment Healthcare Inc | 0.38% | $141.71M |
| Celldex Therapeutics Inc | 0.38% | $140.71M |
| Protagonist Therapeutics Inc | 0.37% | $136.62M |
| Crinetics Pharmaceuticals Inc | 0.37% | $135.51M |
| PTC Therapeutics Inc | 0.36% | $132.61M |
| Acadia Healthcare Co Inc | 0.35% | $130.03M |
| Option Care Health Inc | 0.35% | $128.56M |
| Apogee Therapeutics Inc | 0.34% | $123.57M |
| Structure Therapeutics Inc | 0.33% | $120.59M |
| Immunocore Holdings PLC | 0.32% | $118.51M |
| Inspire Medical Systems Inc | 0.32% | $117.55M |
| Dianthus Therapeutics Inc | 0.30% | $109.27M |
| GenFleet Therapeutics Shanghai Inc | 0.28% | $102.85M |
| Bio-Techne Corp | 0.27% | $100.98M |
| Duality Biotherapeutics Inc | 0.27% | $98.90M |
| Newamsterdam Pharma Co NV | 0.27% | $97.84M |
| Natera Inc | 0.26% | $96.90M |
| Moderna Inc | 0.25% | $91.67M |
| M3 Inc | 0.25% | $91.04M |
| Arcus Biosciences Inc | 0.24% | $87.87M |
| Nuvalent Inc | 0.24% | $87.57M |
| Jiangsu Hengrui Pharmaceuticals Co Ltd | 0.22% | $82.88M |
| HSBC Bank USA | 0.22% | $80.50M |
| Zai Lab Ltd | 0.21% | $78.19M |
| Centene Corp | 0.20% | $73.22M |
| Bridgebio Pharma Inc | 0.19% | $69.90M |
| Immunome Inc | 0.17% | $63.69M |
| Stoke Therapeutics Inc | 0.15% | $54.07M |
| Kailera Therapeutics Inc | 0.14% | $53.18M |
| Mineralys Therapeutics Inc | 0.13% | $49.53M |
| Bank of America Securities, LLC | 0.11% | $39.00M |
| Nomura Securities International, Inc. | 0.11% | $39.00M |
| Aktis Oncology Inc | 0.10% | $37.94M |
| Barclays Capital Inc. | 0.10% | $37.20M |
| Bank of Nova Scotia | 0.09% | $34.30M |
| BNP Paribas Securities Corp. | 0.09% | $34.20M |
| Shandong Weigao Group Medical Polymer Co Ltd | 0.09% | $33.98M |
| Bank of America Securities, LLC | 0.08% | $31.10M |
| Vanguard Cmt Funds-Vanguard Market Liquidity Fund | 0.08% | $30.03M |
| BNP Paribas Securities Corp. | 0.08% | $30.00M |
| JP Morgan Securities LLC | 0.08% | $29.00M |
| Nomura Securities International, Inc. | 0.07% | $25.00M |
| Bank of America Securities, LLC | 0.07% | $25.00M |
| Credit Agricole | 0.06% | $21.50M |
| Natixis SA | 0.05% | $17.30M |
| HSBC Bank USA | 0.03% | $9.40M |
VGHAX overview: performance, fees, allocation and SEC filings